You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNS Lymphoma

Showing 1 - 25 of 6,248
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study

Not yet recruiting
  • CNS Lymphoma
    • London, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Apr 12, 2023

    CNS Lymphoma Trial in Essen ([90Y]Y-PentixaTher)

    Recruiting
    • CNS Lymphoma
    • Essen, Germany
      University Hospital Essen
    Nov 16, 2023

    CNS Lymphoma Trial (68Ga-PTF)

    Recruiting
    • CNS Lymphoma
    • Aalborg, Denmark
    • +1 more
    Jan 17, 2023

    Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

    Recruiting
    • Lymphoma
    • Lymphoma Cns
    • Boston, Massachusetts
    • +1 more
    Jan 3, 2023

    CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)

    Recruiting
    • CNS Lymphoma
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Aug 10, 2022

    Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • (no location specified)
    Aug 11, 2023

    Primary CNS Lymphoma Trial in London (CD19CAR T-cells)

    Recruiting
    • Primary CNS Lymphoma
    • CD19CAR T-cells
    • London, United Kingdom
      University College London Hospital
    Jun 13, 2022

    Primary CNS Lymphoma Trial in San Francisco (Hyperpolarized pyruvate (13C), Magnetic resonance imaging (MRI))

    Recruiting
    • Primary CNS Lymphoma
    • Hyperpolarized pyruvate (13C)
    • Magnetic resonance imaging (MRI)
    • San Francisco, California
      University of California, San Francisco
    Apr 22, 2022

    CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Chemotherapy)

    Not yet recruiting
    • CNS Lymphoma
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Jun 22, 2023

    Primary CNS Lymphoma Trial in Stuttgart (Venetoclax, Obinutuzumab)

    Terminated
    • Primary CNS Lymphoma
    • Stuttgart, Baden-Württemberg, Germany
      Klinikum Stuttgart
    Jan 18, 2022

    CNS Lymphoma Trial in Petah Tikva (Imbruvica)

    Recruiting
    • Central Nervous System Lymphoma
    • Petah Tikva, Israel
      Hematology Institute
    May 9, 2022

    Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

    Recruiting
    • Primary CNS Lymphoma
    • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
    • Moscow, Russian Federation
      Nathional Medical Research Center for Hematology
    Jun 16, 2022

    Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FTD regimen)

    Completed
    • Primary CNS Lymphoma (PCNSL)
    • HD-MTX-Ara-C regimen
    • FTD regimen
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    Mar 2, 2022

    CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,

    Active, not recruiting
    • CNS Lymphoma
    • +2 more
    • Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
    • Basking Ridge, New Jersey
    • +2 more
    Jan 27, 2023

    CNS Lymphoma Trial in Worldwide (GB5121)

    Recruiting
    • CNS Lymphoma
    • Phoenix, Arizona
    • +5 more
    Jul 26, 2022

    CNS Lymphoma Trial in Beijing (Zanubrutinib)

    Recruiting
    • CNS Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Aug 1, 2022

    CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

    Active, not recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • DISEASE
    • (no location specified)
    May 4, 2023

    Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

    Recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
      • Milan, Italy
        Ospedale San Raffaele
      Aug 29, 2023

      Primary CNS Lymphoma Trial in Stuttgart (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix,

      Recruiting
      • Primary Central Nervous System Lymphoma
      • Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix
      • Control intervention: four courses of MATRix
      • Stuttgart, Baden-Württemberg, Germany
        Klinikum Stuttgart
      Feb 15, 2022

      Primary CNS Lymphoma Trial in Paris (PET-MRI)

      Not yet recruiting
      • Primary Central Nervous System Lymphoma
      • Paris, France
        Hôpital Pitié Salpêtrière
      May 20, 2022

      Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)

      Recruiting
      • Primary Central Nervous System Lymphoma
      • +2 more
      • Guandong, Guangdong, China
      • +2 more
      Apr 6, 2022

      CNS Lymphoma Trial in Aarhus (Immunochemo)

      Completed
      • Central Nervous System Lymphoma
      • Aarhus, Denmark
        Elisa Jacobsen Pulczynski
      Aug 3, 2022

      Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

      Recruiting
      • Secondary Central Nervous System Lymphoma
      • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
      • Beijing, Beijing, China
        Peking University Cancer Hospital & Institute
      May 25, 2022

      Advanced Solid Tumor, Recurrent Glioma, CNS Lymphoma Trial in United States (PRT811)

      Active, not recruiting
      • Advanced Solid Tumor
      • Recurrent Glioma
      • Denver, Colorado
      • +9 more
      Dec 16, 2022

      Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

      Not yet recruiting
      • Non-hodgkin Lymphoma, B Cell
      • ctDNA detection
      • Aarau, Switzerland
      • +12 more
      Oct 18, 2023